Finance

Lists
Why is ELTX down 4.86%?
Dive Deeper
ELTX:NASDAQ
Elicio Therapeutics Inc
$1.76
-4.86%
(-0.090) 1D
Oct 8, 11:52:54 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELTX...
Open
$1.85
High
$1.85
Low
$1.74
Mkt. cap
46.26M
Avg. vol.
340.33K
Volume
59.02K
52-wk high
$16.00
52-wk low
$1.72
EPS
-$2.18
Beta
1.32
Shares outstanding
26.28M
No. of employees
33
Open
$1.85
High
$1.85
Low
$1.74
Mkt. cap
46.26M
Avg. vol.
340.33K
Volume
59.02K
52-wk high
$16.00
52-wk low
$1.72
EPS
-$2.18
Beta
1.32
Shares outstanding
26.28M
No. of employees
33
News stories
From web sources and news partners
About Elicio Therapeutics Inc
CEO-
Employees33
Founded2011
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiteelicio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ELTX in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ELTX in the last 3 months.
Highest
Current $1.76
$23.00 (+1,206.82%)
Average
$15.50 (+780.68%)
Lowest
$8.00 (+354.55%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mayank Mamtani
B. Riley Securities
Buy
Maintained
$8.00
+354.5%
09/24/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$23.00
+1,206.8%
08/21/2026
Boris Peaker
JonesTrading
Hold
Reiterated
-
-
08/17/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
$12.00
+581.8%
06/18/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
$20.00
+1,036.4%
04/15/2026
Soumit Roy
JonesTrading
Buy
Maintained
$18.00
+922.7%
04/06/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$17.00
+865.9%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.04M
5.08M
6.76M
6.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.01M
3.76M
3.84M
3.62M
Operating expense
8.04M
8.84M
10.60M
10.43M
Total operating expenses
8.04M
8.84M
10.60M
10.43M
Operating income
-8.04M
-8.84M
-10.60M
-10.43M
Other non operating income
-1.81M
1.26M
-984.00K
2.48M
EBT including unusual items
-10.08M
-7.72M
-11.82M
-8.22M
EBT excluding unusual items
-10.08M
-7.72M
-11.82M
-8.22M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.08M
-7.72M
-11.82M
-8.22M
Net profit margin
-
-
-
-
Earnings per share
-0.60
-0.49
-0.65
-0.43
Interest and investment income
199.00K
199.00K
157.00K
138.00K
Interest expense
-426.00K
-337.00K
-407.00K
-410.00K
Net interest expenses
-227.00K
-138.00K
-250.00K
-272.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.00M
-8.79M
-10.56M
-10.39M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps